These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Amiodarone for cardiac arrhythmias. Key management issues for NPs. McLemore R Adv Nurse Pract; 2001 Apr; 9(4):69-71. PubMed ID: 12420439 [No Abstract] [Full Text] [Related]
48. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents]. Fujiki A Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075 [No Abstract] [Full Text] [Related]
49. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Marcus FI; Fontaine GH; Frank R; Grosgogeat Y Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975 [No Abstract] [Full Text] [Related]
50. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Etheridge SP; Craig JE; Compton SJ Am Heart J; 2001 Jan; 141(1):105-10. PubMed ID: 11136494 [TBL] [Abstract][Full Text] [Related]
51. Clinical efficacy and safety of intravenous Amiodarone in infants and children. Figa FH; Gow RM; Hamilton RM; Freedom RM Am J Cardiol; 1994 Sep; 74(6):573-7. PubMed ID: 8074040 [TBL] [Abstract][Full Text] [Related]
52. Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause? Yildirim SV; Tiker F; Cengiz N; Kiliçdağ H Pediatr Cardiol; 2005; 26(6):879-80. PubMed ID: 16235017 [TBL] [Abstract][Full Text] [Related]
53. Toxic effects of drugs used in the ICU. Antiarrhythmic agents. Nolan PE; Raehl CL Crit Care Clin; 1991 Jul; 7(3):507-20. PubMed ID: 1863880 [TBL] [Abstract][Full Text] [Related]
56. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias. Hamer AW; Finerman WB; Peter T; Mandel WJ Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716 [TBL] [Abstract][Full Text] [Related]
57. [Fetal supraventricular tachyarrhythmias refractory to initial therapy]. Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808 [TBL] [Abstract][Full Text] [Related]
58. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. Perry JC; Fenrich AL; Hulse JE; Triedman JK; Friedman RA; Lamberti JJ J Am Coll Cardiol; 1996 Apr; 27(5):1246-50. PubMed ID: 8609351 [TBL] [Abstract][Full Text] [Related]
59. [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent]. Malpartida F; Triola M; Huguet R; Sala J; Noguera J; Cordeiro B Rev Med Univ Navarra; 1975; 19(1):143-9. PubMed ID: 1234780 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias. Schmidt A; König W; Binner L; Mayer U; Stauch M Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]